VJHemOnc is committed to improving our service to you

EHA 2020 | HD17: PET guided omission of radiotherapy in Hodgkin lymphoma

VJHemOnc is committed to improving our service to you

Peter Borchmann

Peter Borchmann, MD , University Hospital Cologne, Cologne, Germany, discusses HD17 (NCT01356680), a Phase III trial of PET-guided omission of radiotherapy in early-stage unfavorable Hodgkin lymphoma patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter